麝香保心丸联合常规西药治疗老年冠心病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Clinical Study on Shexiang Baoxin Pills Combined with Routine Western Medicine for Coronary Heart Disease in the Senile
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察麝香保心丸联合常规西药治疗老年冠心病的临床疗效。方法:选取老年冠心病患者130 例,按随机数字表法分为研究组和对照组各65 例。对照组给予常规西药治疗,研究组在对照组基础上给予麝香保心丸治疗。评价2 组临床疗效,比较2 组治疗前后炎症因子及外周血micro RNA-126 表达变化,并观察不良反应发生情况。结果:研究组总有效率为98.46%,高于对照组89.23%(P<0.05)。治疗前,2 组血清肿瘤坏死因子-α(TNF-α)、超敏C-反应蛋白(hs-CRP) 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组血清TNF-α、hs-CRP 水平低于治疗前(P<0.05),且观察组血清TNF-α、hs-CRP 水平低于对照组(P<0.05)。治疗前,2 组血清micro RNA-126 表达水平比较,差异无统计学意义(P>0.05)。治疗后,2 组血清micro RNA-126 表达水平高于治疗前(P<0.05),研究组血清micro RNA-126 表达水平高于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:麝香保心丸联合常规西药治疗老年冠心病患者能促进外周血micro RNA-126 表达,抑制炎症因子生成,从而提高治疗效果。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Shexiang Baoxin Pills combined with routine western medicine for coronary heart disease in the senile. Methods:A total of 130 cases of senile patients with coronary heart disease were divided into the study group and the control group according to the random number table method, with 65 cases in each group. The control group was treated with routine western medicine, and the study group was additionally treated with Shexiang Baoxin Pills based on the treatment of the control group. The clinical effects in the two groups were evaluated. Before and after treatment, the changes in inflammatory factors and expressions of micro RNA- 126 in peripheral blood were compared between the two groups. The incidence of adverse reactions was observed. Results:The total effective rate was 98.46% in the study group, higher than that of 89.23% in the control group(P< 0.05). Before treatment, there was no significant difference being found in the comparison of levels of tumor necrosis factor- α(TNF- α) and high- sensitivity C- reactive protein(hs- CRP) in serum between the two groups(P>0.05). After treatment,the levels of TNF-α and hs-CRP in serum in the two groups were lower than those before treatment(P<0.05), and the levels of TNF- α and hs- CRP in serum in the observation group were lower than those in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of expression levels of micro RNA- 126 in serum between the two groups(P>0.05). After treatment,the expression levels of micro RNA- 126 in serum in the two groups were higher than those before treatment(P<0.05),and the expression level of micro RNA- 126 in serum in the study group was higher than that in the control group(P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups(P> 0.05). Conclusion: Shexiang Baoxin Pills combined with routine western medicine for coronary heart disease in the senile can promote the expression of micro RNA- 126 in peripheral blood and inhibit the generation of inflammatory factors,so as to improve the curative effect.

    参考文献
    相似文献
    引证文献
引用本文

张菲斐,王海洋,白洋,申文宇,刘儒,李贞彩.麝香保心丸联合常规西药治疗老年冠心病临床研究[J].新中医,2022,54(23):61-64

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-12-11
  • 出版日期:
文章二维码